Low-dose Aspirin Use to Prevent Colorectal Cancer and Cardiovascular Disease
The American Cancer Society (ACS) estimates 151,030 new cases and 52,580 deaths from colorectal cancer (CRC) in 2022.
The gastroenterology nurse sees many patients for CRC screening and a variety of gastroenteric conditions. This population may have been started on low-dose aspirin for CVD prevention or CRC chemoprevention. The updated and more restricted USPSTF (2022) recommendations should be used to guide their treatment.
Morrow, L., & Greenwald, B. (2023). Low-dose aspirin use to prevent colorectal cancer and cardiovascular disease. Gastroenterology Nursing, 46(1), 76-77. Doi.org/10.1097/SGA.0000000000000680